ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

リコンビナントタンパク質

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
GA1-H52W9
製品名称
Human LRRC32&TGF-beta 1 Heterotrimer protein, His Tag&Tag Free (MALS verified)
タンパク質名
LRRC32 & TGF-beta 1
Species
Human
HOST
HEK293
1mg: 711200円
お問い合わせ
1mg: 302400円
お問い合わせ

Overview

Synonyms -
Characteristics Human LRRC32&TGFB1 Heterotrimer protein, His Tag&Tag Free (the molar ratio of LRRC32 & TGF-beta 1 equals 1:2) is produced by co-expression of LRRC32 and TGF-beta 1, which has a calculated MW of 68.0 kDa (LRRC32), 28.5 (LAP) and 14.8 kDa (mature TGF-beta 1) respectively. LRRC32 is fused with a polyhistidine tag at the C-terminus and TGF-beta 1 contains no tag. The reducing (R) Heterotrimer protein migrates as 70 kDa (LRRC32), 38-45 kDa (LAP) and 14 kDa (mature TGF-beta 1) due to glycosylation respectively.
Endotoxin Level 1.0 EU per μg
Purity 90%
Description GARP (LRRC32) is a transmembrane protein that binds latent-TGF-β1 and tethers it on the Treg surface. and has been proved to promote the activation and secretion of transforming growth factor β (TGF-β). The expression of GARP is highly on the surface activated Tregs and increases the suppressive function of Tregs. Additionally, GARP can bind to latent transforming growth factor β (TGF-β), thus promoting secretion and activation of TGF-β. TGF-β plays a critical rule for homeostasis and function of Tregs. Notably, it has been also observed that fibroblasts and endothelial cell lines that express GARP/latent TGF-β1 complexes do not activate TGF-β1. However, it cannot be excluded that specific stimuli are required to trigger TGF-β1 activation from complexes on the surface of these cell types.
Reference -
URL https://www.acrobiosystems.com/P4265-Human-LRRC32TGF-beta-1-Heterotrimer-protein-His-TagTag-Free-%28MALS-verified%29.html

お問い合わせリスト(-)

お問い合わせフォーム